Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Naltrexone implant - Shenzhen ScienCare Pharmaceutical

Next Previous
Drug Profile

Naltrexone implant - Shenzhen ScienCare Pharmaceutical

Alternative Names: SK-1801; SK-2007

Latest Information Update: 04 Mar 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Shenzhen ScienCare Pharmaceutical
  • Class Alcohols; Anti-inflammatories; Antineoplastics; Antivirals; Cyclic ethers; Cyclohexanes; Cyclopropanes; Drug withdrawal therapies; Ethers; Eye disorder therapies; Furans; Irritable bowel syndrome therapies; Ketones; Morphinans; Naphthols; Non-opioid analgesics; Phenanthrenes; Phenols; Piperidines; Small molecules
  • Mechanism of Action Opioid receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Alcoholism
  • Phase Unknown Opioid-related disorders

Most Recent Events

  • 25 Feb 2026 Shenzhen Sciencare Medical Industries plans phase III (Diagnosis) in March 2026 (SC) (NCT07433413)
  • 19 Jul 2023 Investigation in Opioid related disorders in China (SC) (Shenzhen ScienCare Pharmaceutical pipeline, July 2023)
  • 16 Jun 2023 Phase-I clinical trials in Alcoholism in China (SC) (NCT05919017)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top